MedTrace Logo

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

NCT05346991 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1102

Last updated 2022-04-26

No results posted yet for this study

Summary

Disseminating an evidence-based tobacco control intervention for School Teachers

Conditions

  • Tobacco Use Cessation

Interventions

OTHER

Tobacco Free Teachers, Tobacco Free Society program

The Tobacco Free Teachers, Tobacco Free Society (TFT-TFS) program provides teachers with the knowledge and skills to quit tobacco use, or to help someone else quit; it also helps schools comply with national tobacco control policies. School principals implement four TFT-TFS program components with teachers in their schools during school hours across an academic year (August-April): * Adopting a school tobacco control policy * Providing cessation support (e.g. distribution of self-help quit booklets and referrals to government cessation resources) * Conducting monthly group discussions with teachers about tobacco * Hanging six thematic posters in the school With the goal of establishing a tobacco-free school environment, the program incorporates six program themes: 1. Teachers as Role Models; 2. Health Effects of Tobacco; 3. Motivation to Quit-or Help Others to Quit; 4. Skills to Quit; 5. Dealing with Withdrawal; and 6. Maintenance and Celebration.

Sponsors & Collaborators

  • Healis-Sekhsaria Institute for Public Health

    collaborator OTHER

  • Glorian Sorensen

    lead OTHER

Principal Investigators

  • Glorian Sorensen, PhD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-06-30
Completion
2020-07-31

Countries

  • United States
  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05346991 on ClinicalTrials.gov